Latest Insider Transactions at Gluco Track, Inc. (GCTK)
This section provides a real-time view of insider transactions for Gluco Track, Inc. (GCTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GlucoTrack, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GlucoTrack, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2025
|
John Ballantyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+50.0%
|
-
|
|
Mar 26
2025
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,076
+1.42%
|
-
|
|
Mar 26
2025
|
Erin Catherine Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+3.99%
|
-
|
|
Mar 26
2025
|
Allen Danzig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,498
+43.8%
|
-
|
|
Mar 26
2025
|
Andrew K Balo Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,490
+50.0%
|
-
|
|
Mar 26
2025
|
Robert Fischell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,498
+42.28%
|
-
|
|
Mar 12
2025
|
John A. Ballantyne Revocable Living Trust Dated 08/01/2017 > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
2,560,553
+48.27%
|
-
|
|
Mar 12
2025
|
John Ballantyne Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,560,553
+48.27%
|
-
|
|
Mar 12
2025
|
Luis Malave Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
133,532
+48.54%
|
-
|
|
Mar 12
2025
|
Erin Catherine Carter Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
40,297
+47.95%
|
-
|
|
Mar 12
2025
|
Paul Goode Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
15,435
+44.84%
|
-
|
|
Feb 05
2025
|
Paul Goode Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,500
+29.68%
|
-
|
|
Nov 14
2024
|
John A. Ballantyne Revocable Living Trust Dated 08/01/2017 > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
132,036
+41.91%
|
$4,093,116
$31.0 P/Share
|
|
Nov 14
2024
|
John Ballantyne Director |
BUY
Other acquisition or disposition
|
Indirect |
132,036
+41.91%
|
$4,093,116
$31.0 P/Share
|
|
Nov 14
2024
|
Luis Malave Director |
BUY
Conversion of derivative security
|
Direct |
6,886
+46.23%
|
$213,466
$31.2 P/Share
|
|
Nov 14
2024
|
Erin Catherine Carter Director |
BUY
Conversion of derivative security
|
Direct |
2,078
+37.67%
|
$64,418
$31.2 P/Share
|
|
Nov 14
2024
|
Paul Goode Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
796
+27.93%
|
$24,676
$31.2 P/Share
|
|
Apr 22
2024
|
Drew Sycoff Director |
BUY
Open market or private purchase
|
Direct |
182,539
+5.82%
|
$182,539
$1.26 P/Share
|
|
Apr 08
2024
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
489
+30.34%
|
-
|
|
Apr 08
2024
|
Erin Catherine Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
458
+25.18%
|
-
|
|
Apr 08
2024
|
Allen Danzig Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+35.07%
|
-
|
|
Apr 08
2024
|
Robert Fischell Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+29.51%
|
-
|
|
Dec 31
2023
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+36.35%
|
-
|
|
Dec 31
2023
|
Erin Catherine Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
903
+50.0%
|
-
|
|
Apr 20
2023
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
121
+30.79%
|
-
|
|
Jan 09
2023
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
29
+16.11%
|
-
|
|
Oct 04
2022
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
44
+26.51%
|
-
|
|
Oct 04
2022
|
Allen Danzig Director |
BUY
Grant, award, or other acquisition
|
Direct |
44
+18.41%
|
-
|
|
Jun 30
2022
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+30.36%
|
-
|
|
Mar 31
2022
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+36.23%
|
-
|
|
Dec 31
2021
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+36.67%
|
-
|
|
Sep 30
2021
|
Luis Malave Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+50.0%
|
-
|
|
Aug 24
2021
|
Robert Fischell Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+50.0%
|
-
|